Erick Lucera Insider Profile
4 Followers
Erick Lucera, CFO at Dyne Therapeutics, holds 121.56K shares in Dyne Therapeutics (Ticker: DYN), holds 43.61K shares in Beyond Air (Ticker: XAIR), holds ― shares in AVEO Pharma (Ticker: AVEO). Most recently, Erick Lucera Sold ― shares of Dyne Therapeutics on Jun 26, 2026 for an estimated value of $48.11K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-56.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Erick Lucera holds in companies
Most Profitable Insider Trade
The most profitable trade made by Erick Lucera
Erick Lucera's Trading History
Dyne Therapeutics
Jun 26, 2026
CFO
Informative Sell
48.11K
$3.18M
Beyond Air
Aug 15, 2024
Director
Informative Buy
15.31K
$263.83K
AVEO Pharma
―
―
―
―
Valeritas Holdings
―
―
―
―
Bone Biologics
―
Director
―
―
SAB Biotherapeutics
―
Director
―
―
Editas Medicine
Mar 05, 2025
EVP & CFO
Uninformative Sell
7.03K
$320.12K
List of latest transactions for each holding click on a transaction to see Erick Lucera's performance on stock
You May Also Like
Erick Lucera insider profile FAQ
What is the percentage of profitable transactions made by Erick Lucera?
The percentage of profitable transactions made by Erick Lucera is 0%.
What is the average return per transaction made by Erick Lucera?
The average return per transaction made by Erick Lucera is -56.70%.
What stocks does Erick Lucera hold?
Erick Lucera holds: DYN, XAIR, AVEO, VLRXQ, BBLG, SABS, EDIT stocks.
What was Erick Lucera’s latest transaction?
Erick Lucera latest transaction was an Informative Sell of $48.11K.
What was Erick Lucera's most profitable transaction?
Erick Lucera’s most profitable transaction was an Informative Sell of DYN stock on June 26, 2026. The return on the trade was -25.30%.
What is Erick Lucera's role in Dyne Therapeutics?
Erick Lucera's role in Dyne Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.